{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:12:02Z","timestamp":1794366722081,"version":"4.9.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Cardiac magnetic resonance (CMR) imaging is a key test in the diagnosis of cardiac amyloidosis (CA). Extracardiac involvement is common in light chain (AL) amyloidosis and MRI findings may assist in its diagnosis. We sought to investigate the utility of splenic CMR parameters for the diagnosis of CA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-four patients with AL amyloidosis and 32 patients with severe left ventricular hypertrophy in the setting of aortic stenosis (LVH-AS) who completed 3T cardiac MRI at the time of their diagnosis of AL or LVH-AS were assessed with T1, T2 (modified Look-Locker inversion recovery), extracellular volume (ECV) mapping, and late gadolinium enhancement (LGE) imaging of the heart and spleen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Age, left ventricular mass index, wall thickness, ejection fraction, and splenic dimensions did not differ significantly between groups. All AL patients had cardiac involvement. T1 and T2 spleen mapping did not differ significantly between groups but AL patients had higher median ECV in the spleen than in LVH-AS (AL 46.9%, LVH-AS: 31%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and significantly lower short tau inversion recovery ratio (AL: 1.7, LVH-AS: 2.7,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) both with very good diagnostic performance to diagnose AL. We identified 16 AL patients with spleen involvement and 16 without. Spleen ECV and \u201cnormalized\u201d spleen ratio, defined as the ratio of spleen LGE to muscle values exhibited strong correlation and had excellent diagnostic performance to discriminate those with spleen involvement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings show that spleen CMR parameters can identify spleen involvement in AL patients and differentiate them from those without AL amyloidosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-022-01194-8","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:05:19Z","timestamp":1648544719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0899-0515","authenticated-orcid":false,"given":"Niki","family":"Lama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Karavasilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Chasouraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Alexopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Spiliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Theodorakakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos L.","family":"Kelekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"1194_CR1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000506696","volume":"143","author":"MM Picken","year":"2020","unstructured":"Picken MM (2020) The pathology of amyloidosis in classification: a review. Acta Haematol 143:322\u2013334. https:\/\/doi.org\/10.1159\/000506696","journal-title":"Acta Haematol"},{"key":"1194_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100636","volume":"40","author":"I Vaxman","year":"2020","unstructured":"Vaxman I, Dispenzieri A, Muchtar E, Gertz M (2020) New developments in diagnosis, risk assessment and management in systemic amyloidosis. Blood Rev 40:100636. https:\/\/doi.org\/10.1016\/j.blre.2019.100636","journal-title":"Blood Rev"},{"key":"1194_CR3","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/j.hlc.2021.07.007","volume":"30","author":"N Lama","year":"2021","unstructured":"Lama N, Briasoulis A, Kelekis N, Kastritis E (2021) The utility of non-LGE cardiac magnetic resonance imaging parameters in the diagnosis of cardiac amyloidosis. Heart Lung Circ 30:e137\u2013e138. https:\/\/doi.org\/10.1016\/j.hlc.2021.07.007","journal-title":"Heart Lung Circ"},{"key":"1194_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.121.012506","author":"L Chacko","year":"2021","unstructured":"Chacko L, Boldrini M, Martone R et al (2021) Cardiac magnetic resonance-derived extracellular volume mapping for the quantification of hepatic and splenic amyloid. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/CIRCIMAGING.121.012506","journal-title":"Circ Cardiovasc Imaging"},{"key":"1194_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00041552-200211000-00013","volume":"11","author":"PN Hawkins","year":"2002","unstructured":"Hawkins PN (2002) Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 11:649\u2013655. https:\/\/doi.org\/10.1097\/00041552-200211000-00013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1194_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bjh.15867","volume":"186","author":"K Hanlon","year":"2019","unstructured":"Hanlon K, Wilson MR, Kay D, Jackson B, Leach M (2019) Safety and diagnostic yield of splenic core biopsy; a methodical approach using combined Haematology\/Radiology assessment in a tertiary referral centre. Br J Haematol 186:371\u2013373. https:\/\/doi.org\/10.1111\/bjh.15867","journal-title":"Br J Haematol"},{"key":"1194_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5152\/dir.2017.16484","volume":"23","author":"HN Ozcan","year":"2017","unstructured":"Ozcan HN, Haliloglu M, Sokmensuer C, Akata D, Ozmen M, Karcaaltincaba M (2017) Imaging for abdominal involvement in amyloidosis. Diagn Interv Radiol 23:282\u2013285. https:\/\/doi.org\/10.5152\/dir.2017.16484","journal-title":"Diagn Interv Radiol"},{"key":"1194_CR8","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","volume":"121","author":"AD Wechalekar","year":"2013","unstructured":"Wechalekar AD, Schonland SO, Kastritis E et al (2013) A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood 121:3420\u20133427. https:\/\/doi.org\/10.1182\/blood-2012-12-473066","journal-title":"Blood"},{"key":"1194_CR9","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","volume":"74","author":"J Ternacle","year":"2019","unstructured":"Ternacle J, Krapf L, Mohty D et al (2019) Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol 74:2638\u20132651. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.056","journal-title":"J Am Coll Cardiol"},{"key":"1194_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/bjh.13156","volume":"168","author":"JD Gillmore","year":"2015","unstructured":"Gillmore JD, Wechalekar A, Bird J et al (2015) Guidelines on the diagnosis and investigation of AL amyloidosis. Br J Haematol 168:207\u2013218. https:\/\/doi.org\/10.1111\/bjh.13156","journal-title":"Br J Haematol"},{"key":"1194_CR11","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","volume":"142","author":"MM Kittleson","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV et al (2020) Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation 142:e7\u2013e22. https:\/\/doi.org\/10.1161\/CIR.0000000000000792","journal-title":"Circulation"},{"key":"1194_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/232649","volume":"2015","author":"I Carbone","year":"2015","unstructured":"Carbone I, Childs H, Aljizeeri A, Merchant N, Friedrich MG (2015) Importance of reference muscle selection in quantitative signal intensity analysis of T2-weighted images of myocardial edema using a T2 ratio method. Biomed Res Int 2015:232649. https:\/\/doi.org\/10.1155\/2015\/232649","journal-title":"Biomed Res Int"},{"issue":"355","key":"1194_CR13","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/j.amjmed.2005.08.043","volume":"119","author":"BP Hazenberg","year":"2006","unstructured":"Hazenberg BP, van Rijswijk MH, Piers DA et al (2006) Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 119(355):e315-324. https:\/\/doi.org\/10.1016\/j.amjmed.2005.08.043","journal-title":"Am J Med"},{"key":"1194_CR14","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s00261-017-1194-4","volume":"42","author":"J Yeung","year":"2017","unstructured":"Yeung J, Sivarajan S, Treibel TA et al (2017) Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT. Abdom Radiol (NY) 42:2646\u20132651. https:\/\/doi.org\/10.1007\/s00261-017-1194-4","journal-title":"Abdom Radiol (NY)"},{"key":"1194_CR15","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1148\/radiol.13121889","volume":"268","author":"S Bandula","year":"2013","unstructured":"Bandula S, Banypersad SM, Sado D et al (2013) Measurement of tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging. Radiology 268:858\u2013864. https:\/\/doi.org\/10.1148\/radiol.13121889","journal-title":"Radiology"},{"key":"1194_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s00261-005-0317-5","volume":"30","author":"PP Mainenti","year":"2005","unstructured":"Mainenti PP, Camera L, Nicotra S et al (2005) Splenic hypoperfusion as a sign of systemic amyloidosis. Abdom Imaging 30:768\u2013772. https:\/\/doi.org\/10.1007\/s00261-005-0317-5","journal-title":"Abdom Imaging"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-022-01194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-022-01194-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-022-01194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:06:36Z","timestamp":1648544796000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-022-01194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1186\/s13244-022-01194-8","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Local Ethical Committee and was conducted in accordance with the Declaration of Helsinki. All participants provided informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}